Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2

EMBO Journal

Volumn 30, Issue 2, 2011, Pages 417-426

  Newstead, Simon ^a,b,c,e   Drew, David ^a,c   Cameron, Alexander D ^a,b,c   Postis, Vincent L G ^d   Xia, Xiaobing ^d,e   Fowler, Philip W ^e   Ingram, Jean C ^d   Carpenter, Elisabeth P ^a,b,e   Sansom, Mark S P ^e   McPherson, Michael J ^d   Baldwin, Stephen A ^d   Iwata, So ^a,b,c,f,g  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Diamond Light Source   (United Kingdom)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f KYOTO UNIVERSITY   (Japan)

^g RIKEN   (Japan)

Author keywords

major facilitator superfamily transporter; occluded state; peptide transport

Indexed keywords

PEPTIDE TRANSPORTER 1; PEPTIDE TRANSPORTER 2;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SHEWANELLA ONEIDENSIS;

BINDING SITES; CRYSTALLOGRAPHY; MODELS, MOLECULAR; SHEWANELLA; SYMPORTERS;

MAMMALIA; PROKARYOTA; SHEWANELLA ONEIDENSIS;

EID: 78751604619     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2010.309     Document Type: Article

References (63)

1. Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, Iwata S (2003) Structure and mechanism of the lactose permease of Escherichia coli. Science 301: 610-615
2. Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, Moriarty NW, Read RJ, Sacchettini JC, Sauter NK, Terwilliger TC (2002) PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58(Pt 11): 1948-1954
3. Bailey PD, Boyd CA, Bronk JR, Collier ID, Meredith D, Morgan KM, Temple CS (2000) How to make drugs orally active: a substrate template for peptide transporter PepT1. Angew Chem Int Ed Engl 39: 505-508
4. Bapna A, Federici L, Venter H, Velamakanni S, Luisi B, Fan TP, van Veen HW (2007) Two proton translocation pathways in a secondary active multidrug transporter. J Mol Microbiol Biotechnol 12: 197-209
5. Biegel A, Knü tter I, Hartrodt B, Gebauer S, Theis S, Luckner P, Kottra G, Rastetter M, Zebisch K, Thondorf I, Daniel H, Neubert K, Brandsch M (2006) The renal type H+/peptide symporter PEPT2: structure-affinity relationships. Amino Acids 31: 137-156
6. Bolger MB, Haworth IS, Yeung AK, Ann D, von Grafenstein H, Hamm-Alvarez S, Okamoto CT, Kim KJ, Basu SK, Wu S, Lee VH (1998) Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1. J Pharm Sci 87: 1286-1291
7. Boudker O, Verdon G (2010) Structural perspectives on secondary active transporters. Trends Pharmacol Sci 31: 418-426
8. Brandsch M (2009) Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls. Expert Opin Drug Metab Toxicol 5: 887-905
9. Brandsch M, Miyamoto Y, Ganapathy V, Leibach FH (1994) Expression and protein kinase C-dependent regulation of peptide/H+ co-transport system in the Caco-2 human colon carcinoma cell line. Biochem J 299(Pt 1): 253-260
10. BUSTER-TNT 2.X GPL, Sheraton House, Cambridge CB3 0AX, UK
11. BUSTER-TNT 2.X GPL, Sheraton House, Cambridge CB3 0AX, UK Casagrande F, Harder D, Schenk A, Meury M, Ucurum Z, Engel A, Weitz D, Daniel H, Fotiadis D (2009) Projection structure of DtpD (YbgH), a prokaryotic member of the peptide transporter family. J Mol Biol 394: 708-717
12. Chen XZ, Steel A, Hediger MA (2000) Functional roles of histidine and tyrosine residues in the H(+)-peptide transporter PepT1. Biochem Biophys Res Commun 272: 726-730
13. Covitz KM, Amidon GL, Sadée H (1998) Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions. Biochemistry 37: 15214-15221
14. Cowtan K (1994) Joint CCP4 and ESF-EACBM newsletter on protein crystallography. 31: 34-38
15. Daniel H, Kottra G (2004) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch 447: 610-618
16. Daniel H, Spanier B, Kottra G,Weitz D (2006) From bacteria to man: archaic proton-dependent peptide transporters at work. Physiology (Bethesda) 21: 93-102
17. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall III WB, Snoeyink J, Richardson JS, Richardson DC (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35 (Web Server issue): W375-W383
18. de La Fortelle E, Bricogne G (1997) Maximum-likelihood heavyatom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol 276: 472-494
19. Doring F, Martini C,Walter J, Daniel H (2002) Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function. J Membr Biol 186: 55-62
20. Drew DE, von Heijne G, Nordlund P, de Gier JW (2001) Green fluorescent protein as an indicator to monitor membrane protein overexpression in Escherichia coli. FEBS Lett 507: 220-224
21. Ernst HA, Pham A, Hald H, Kastrup JS, Rahman M, Mirza O (2009) Ligand binding analyses of the putative peptide transporter YjdL from E. coli display a significant selectivity towards dipeptides. Biochem Biophys Res Commun 389: 112-116
22. Faria TN, Timoszyk JK, Stouch TR, Vig BS, Landowski CP, Amidon GL, Weaver CD, Wall DA, Smith RL (2004) A novel high-throughput pepT1 transporter assay differentiates between substrates and antagonists. Mol Pharm 1: 67-76
23. Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, Singh SK, Boron WF, Hediger MA (1994) Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368: 563-566 (Pubitemid 24118776)
24. Fei YJ, Liu W, Prasad PD, Kekuda R, Oblak TG, Ganapathy V, Leibach FH (1997) Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2. Biochemistry 36: 452-460
25. Fellouse FA, Wiesmann C, Sidhu SS (2004) Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci USA 101: 12467-12472
26. Ganapathy ME, HuangW,Wang H, Ganapathy V, Leibach FH (1998) Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun 246: 470-475
27. Ganapathy V, Leibach FH (1983) Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brushborder membrane vesicles from the rabbit. Studies with L-carnosine and glycyl-L-proline. J Biol Chem 258: 14189-14192
28. Gbaguidi B, Hakizimana P, Vandenbussche G, Ruysschaert JM (2007) Conformational changes in a bacterial multidrug transporter are phosphatidylethanolamine-dependent. Cell Mol Life Sci 64: 1571-1582
29. Guan L, Kaback HR (2006) Lessons from lactose permease. Annu Rev Biophys Biomol Struct 35: 67-91
30. Hagting A, Kunji ER, Leenhouts KJ, Poolman B, Konings WN (1994) The di-and tripeptide transport protein of Lactococcus lactis. A new type of bacterial peptide transporter. J Biol Chem 269: 11391-11399
31. Harder D, Stolz J, Casagrande F, Obrdlik P, Weitz D, Fotiadis D, Daniel H (2008) DtpB (YhiP) and DtpA (TppB, YdgR) are prototypical proton-dependent peptide transporters of Escherichia coli. FEBS J 275: 3290-3298
32. Hauser M, Kauffman S, Naider F, Becker JM (2005) Substrate preference is altered by mutations in the fifth transmembrane domain of Ptr2p, the di/tri-peptide transporter of Saccharomyces cerevisiae. Mol Membr Biol 22: 215-227
33. Henderson PJF, Macpherson AJ (1986) Assay, genetics, proteins and reconstitution of proton-linked galactose, arabinose and xylose transport systems of Escherichia coli. Methods Enzymol 125: 387-429
34. Huang NC, Liu KH, Lo HJ, Tsay YF (1999) Cloning and functional characterization of an Arabidopsis nitrate transporter gene that encodes a constitutive component of low-affinity uptake. Plant Cell 11: 1381-1392
35. Huang Y, Lemieux MJ, Song J, Auer M, Wang DN (2003) Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301: 616-620
36. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-38, 27-38
37. Jones TA, Kjeldgaard M (1997) Electron-density map interpretation. Methods Enzymol 277: 173-208
38. Kasho VN, Smirnova IN, Kaback HR (2006) Sequence alignment and homology threading reveals prokaryotic and eukaryotic proteins similar to lactose permease. J Mol Biol 358: 1060-1070
39. Knight SD (2000) RSPS version 4.0: a semi-interactive vector-search program for solving heavy-atom derivatives. Acta Crystallogr D Biol Crystallogr 56(Pt 1): 42-47
40. Krishnamurthy H, Piscitelli CL, Gouaux E (2009) Unlocking the molecular secrets of sodium-coupled transporters. Nature 459: 347-355
41. Krissinel E, Henrick K (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1): 2256-2268
42. Nie Y, Zhou Y, Kaback HR (2009) Clogging the periplasmic pathway in LacY. Biochemistry 48: 738-743
43. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276: 307
44. Paulsen IT, Skurray RA (1994) The POT family of transport proteins. Trends Biochem Sci 19: 404
45. Pieri M, Gan C, Bailey P, Meredith D (2009) The transmembrane tyrosines Y56, Y91 and Y167 play important roles in determining the affinity and transport rate of the rabbit proton-coupled peptide transporter PepT1. Int J Biochem Cell Biol 41: 2204-2213
46. Schaedler TA, van Veen HW (2010) A flexible cation binding site in the multidrug major facilitator superfamily transporter LmrP is associated with variable proton coupling. FASEB J 24: 3653-3661
47. Scott KA, Bond PJ, Ivetac A, Chetwynd AP, Khalid S, Sansom MS (2008) Coarse-grained MD simulations of membrane proteinbilayer self-assembly. Structure 16: 621-630
48. Shimamura T, Weyand S, Beckstein O, Rutherford NG, Hadden JM, Sharples D, Sansom MS, Iwata S, Henderson PJ, Cameron AD (2010) Molecular basis of alternating access membrane transport by the sodium-hydantoin transporter Mhp1. Science 328: 470-473
49. Steiner HY, Naider F, Becker JM (1995) The PTR family: a new group of peptide transporters. Mol Microbiol 16: 825-834
50. Strong M, Sawaya MR, Wang S, Phillips M, Cascio D, Eisenberg D (2006) Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci USA 103: 8060-8065
51. Tamai I, Nakanishi T, Hayashi K, Terao T, Sai Y, Shiraga T, Miyamoto K, Takeda E, Higashida H, Tsuji A (1997) The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine. J Pharm Pharmacol 49: 796-801
52. Tame JR, Sleigh SH, Wilkinson AJ, Ladbury JE (1996) The role of water in sequence-independent ligand binding by an oligopeptide transporter protein. Nat Struct Biol 3: 998-1001
53. Terada T, Irie M, Okuda M, Inui K (2004) Genetic variant Arg57His in human H+/peptide cotransporter 2 causes a complete loss of transport function. Biochem Biophys Res Commun 316: 416-420
54. Terada T, Saito H, Mukai M, Inui KI (1996) Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1. FEBS Lett 394: 196-200 (Pubitemid 26341505)
55. Terada T, Saito H, Mukai M, Inui K (1997) Recognition of betalactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells. Am J Physiol 273(5 Pt 2): F706-F711
56. The PyMOL Molecular Graphics System Version 1.2r3pre, Schrödinger LLC Tsuda M, Terada T, Irie M, Katsura T, Niida A, Tomita K, Fujii N, Inui K (2006) Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives. J Pharmacol Exp Ther 318: 455-460
57. Uchiyama T, Kulkarni AA, Davies DL, Lee VHL (2003) Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1. Pharm Res 20: 1911-1916
58. Weitz D, Harder D, Casagrande F, Fotiadis D, Obrdlik P, Kelety B, Daniel H (2007) Functional and structural characterization of a prokaryotic peptide transporter with features similar to mammalian PEPT1. J Biol Chem 282: 2832-2839
59. Wenzel U, Thwaites DT, Daniel H (1995) Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter. Br J Pharmacol 116: 3021-3027
60. Xu L, Haworth IS, Kulkarni AA, Bolger MB, Davies DL (2009) Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporter. Pharm Res 26: 2358-2366
61. Yeung AK, Basu SK,Wu SK, Chu C, Okamoto CT, Hamm-Alvarez SF, von Grafenstein H, Shen WC, Kim KJ, Bolger MB, Haworth IS, Ann DK, Lee VH (1998) Molecular identification of a role for tyrosine 167 in the function of the human intestinal protoncoupled dipeptide transporter (hPepT1). Biochem Biophys Res Commun 250: 103-107
62. Yin Y, He X, Szewczyk P, Nguyen T, Chang G (2006) Structure of the multidrug transporter EmrD from Escherichia coli. Science 312: 741-744
63. Zhou Y, Guan L, Freites JA, Kaback HR (2008) Opening and closing of the periplasmic gate in lactose permease. Proc Natl Acad Sci USA 105: 3774-3778